On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...